Objective To study the efficacy of resveratrol soft capsules on fasting blood glucose and early diabetic retinopathy(DR).Methods 60 diabetic patients with DR were randomly divided into 4 groups: A, C, B and D by using digital table method.15 cases in each group.The first three groups received basic treatment plus resveratrol soft capsules, Group A: 250 mg/ead time, orally, twice/day; Group B: 350 mg/each times, orally,twice/day; Group C: 500 mg/each time, orally, twice/day for 12 weeks. D group was the control group (basic treatment: exercise intervention, diet control, insulin and oral hypoglycemic agents), compared before and after treatment 1,8,10,12 weekend DR fasting glucose.And before medication and 12 weeks,retinal fluorescein angiography (fundus fluorescence angiography FFA) was used to detect microvascular changes in the patient’s capillary hemangioma,hemorrhage and leakage area for comparison.Results In C group,after treatment ,FPG(8.6±0.812)mmol/L ratio(6.7±0.714)mmol/L,t=4.752,P=0.037;HbALc:(8.7±0.341)% versus(7.2±0.426)%,t=5.542,P=0.031,ISN:(32.4 ± 0.341)pmol/ml versus (28.3±0.132) pmol/ml,t=6.459,P=0.038,In after group C and D, capillary hemangioma, hemorrhage focal area and leaking focal area were (16.86±1.75)N versas (10.06±1.29)N,t=4.624, P<0.05;(2.24±0.23)mm2 versas(1.45±0.22) mm2,t=2.532, P<0.05,(1.40±0.15) mm2 versas(1.01±0.23) mm2,t=2.605, P<0.05.After treatment, the number of capillary hemangioma was decreased, the area of hemorrhage and the area of leakage were reduced.Conclusions The effect of resveratrol on blood glucose and early retinopathy in diabetic patients is dose dependent,and the effective rate in group C is better than that in group B, and group B was better than groups A and D.
张娴, 刘莉. 白藜芦醇软胶囊对糖尿病患者血糖及早期视网膜病变的疗效观察[J]. 武警医学, 2016, 27(8): 806-809.
ZHANG Xian, and LIU Li. Effects of resveratrol soft capsules on diabetic patients’s blood sugar and early retinopathy. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(8): 806-809.
Lee J H,Song M Y,Song E K,et al.Overexpression of SIRT1 protects pancreatic betta-cells against cytokine toxicity by suppressing the nuclearfactor-kappaB signaling pathway[J].Diabetes,2009,58(2):344-351.
[9]
Um J H,Park S J,Kang H,et al.AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol[J].Diabetes,2010,59(3):554-563.
[10]
Wan T T,Li X F,Sun Y H, et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy[J].Biomed Pharmacother,2015,74(1):145-147.